Mirum Pharmaceuticals, INC. (MIRM) — DEF 14A Filings
All DEF 14A filings from Mirum Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Mirum Pharma Executive Compensation Details Released
— Apr 14, 2025 Risk: low
Mirum Pharmaceuticals, Inc. filed its DEF 14A on April 14, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing inclu -
Mirum Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 23, 2024 Risk: low
Mirum Pharmaceuticals, Inc. (MIRM) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Annual Meeting scheduled for June 5, 2024, in a hybrid form
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX